D. D. Ankola

2.3k total citations · 2 hit papers
11 papers, 1.8k citations indexed

About

D. D. Ankola is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, D. D. Ankola has authored 11 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 4 papers in Biomaterials and 3 papers in Molecular Biology. Recurrent topics in D. D. Ankola's work include Advanced Drug Delivery Systems (4 papers), Coenzyme Q10 studies and effects (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). D. D. Ankola is often cited by papers focused on Advanced Drug Delivery Systems (4 papers), Coenzyme Q10 studies and effects (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). D. D. Ankola collaborates with scholars based in United Kingdom, India and Germany. D. D. Ankola's co-authors include M. N. V. Ravi Kumar, V. Bhardwaj, Vikas Beniwal, Jamaluddin Shaikh, Desh Deepak Singh, Marc Schneider, Claus‐Michael Lehr, Bhoomi Viswanad, Poduri Ramarao and Roberto Solaro and has published in prestigious journals such as Macromolecules, Journal of Controlled Release and Pharmaceutical Research.

In The Last Decade

D. D. Ankola

11 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer

2009 786 citations Jamaluddin Shaikh, D. D. Ankola et al. European Journal of Pharmaceutical Sciences profile →
Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective

2006 671 citations D. D. Ankola, V. Bhardwaj et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. D. Ankola United Kingdom	11	532	506	419	394	239	11	1.8k
Kuntal Maiti India	18	367 0.7×	471 0.9×	256 0.6×	274 0.7×	199 0.8×	25	1.9k
Chawanphat Muangnoi Thailand	23	372 0.7×	376 0.7×	348 0.8×	287 0.7×	196 0.8×	56	1.4k
Shufang Nie China	27	334 0.6×	661 1.3×	508 1.2×	1.5k 3.8×	281 1.2×	58	2.9k
V. Bhardwaj India	17	229 0.4×	615 1.2×	931 2.2×	969 2.5×	274 1.1×	20	2.9k
Manicka V. Vadhanam United States	23	338 0.6×	794 1.6×	218 0.5×	128 0.3×	152 0.6×	50	1.9k
Yuan Zhu China	25	154 0.3×	482 1.0×	299 0.7×	466 1.2×	219 0.9×	57	1.7k
Anoop K. Singh United States	8	1.1k 2.0×	644 1.3×	235 0.6×	132 0.3×	124 0.5×	9	1.7k
Pornchai Rojsitthisak Thailand	28	451 0.8×	596 1.2×	252 0.6×	235 0.6×	83 0.3×	105	1.9k
Yan Xie China	28	116 0.2×	710 1.4×	502 1.2×	419 1.1×	234 1.0×	60	2.5k
Tuba Parlak Ak Türkiye	5	722 1.4×	396 0.8×	157 0.4×	83 0.2×	237 1.0×	11	1.6k

Countries citing papers authored by D. D. Ankola

Since Specialization

Citations

This map shows the geographic impact of D. D. Ankola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. D. Ankola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. D. Ankola more than expected).

Fields of papers citing papers by D. D. Ankola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. D. Ankola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. D. Ankola. The network helps show where D. D. Ankola may publish in the future.

Co-authorship network of co-authors of D. D. Ankola

This figure shows the co-authorship network connecting the top 25 collaborators of D. D. Ankola. A scholar is included among the top collaborators of D. D. Ankola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. D. Ankola. D. D. Ankola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Ankola, D. D., R. M. Wadsworth, & M. N. V. Ravi Kumar. (2011). Nanoparticulate Delivery Can Improve Peroral Bioavailability of Cyclosporine and Match Neoral Cmax Sparing the Kidney from Damage. Journal of Biomedical Nanotechnology. 7(2). 300–307. 13 indexed citations

Ankola, D. D., et al.. (2010). Preparation, characterization andin silicomodeling of biodegradable nanoparticles containing cyclosporine A and coenzyme Q10. Nanotechnology. 21(6). 65104–65104. 11 indexed citations

Ankola, D. D., et al.. (2010). Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives. Current Opinion in Colloid & Interface Science. 16(3). 238–245. 33 indexed citations

Ankola, D. D., Antonella Battisti, Roberto Solaro, & M. N. V. Ravi Kumar. (2010). Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A. Journal of The Royal Society Interface. 7(suppl_4). S475–81. 15 indexed citations

Shaikh, Jamaluddin, D. D. Ankola, Vikas Beniwal, Desh Deepak Singh, & M. N. V. Ravi Kumar. (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. European Journal of Pharmaceutical Sciences. 37(3-4). 223–230. 786 indexed citations breakdown →

Bhardwaj, V., et al.. (2009). PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat. Pharmaceutical Research. 26(11). 2495–2503. 125 indexed citations

Ankola, D. D., M. N. V. Ravi Kumar, Emo Chiellini, & Roberto Solaro. (2009). Multiblock Copolymers of Lactic Acid and Ethylene Glycol Containing Periodic Side-Chain Carboxyl Groups: Synthesis, Characterization, and Nanoparticle Preparation. Macromolecules. 42(19). 7388–7395. 15 indexed citations

Datta, P.K., et al.. (2008). Nanoparticles Enhance Per Oral Bioavailability of Poorly Available Molecules: Epigallocatechin Gallate Nanoparticles Ameliorates Cyclosporine Induced Nephrotoxicity in Rats at Three Times Lower Dose Than Oral Solution. Journal of Biomedical Nanotechnology. 4(3). 304–312. 31 indexed citations

Godugu, Chandraiah, et al.. (2008). Oral Nanoparticulate Atorvastatin Calcium is More Efficient and Safe in Comparison to Lipicure^® in Treating Hyperlipidemia. Lipids. 43(3). 231–241. 36 indexed citations

10.

Ankola, D. D., Bhoomi Viswanad, V. Bhardwaj, Poduri Ramarao, & M. N. V. Ravi Kumar. (2007). Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?. European Journal of Pharmaceutics and Biopharmaceutics. 67(2). 361–369. 91 indexed citations

11.

Ankola, D. D., et al.. (2006). Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. Journal of Controlled Release. 113(3). 189–207. 671 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact